Analysts at Lake Street Capital assumed coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Get Free Report) in a research report issued on Wednesday, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $20.00 price target on the stock. Lake Street Capital’s target price would indicate a potential upside of 255.24% from the company’s current price.
Several other equities analysts also recently commented on AVR. TD Cowen initiated coverage on Anteris Technologies Global in a research report on Tuesday. They set a “buy” rating and a $15.00 target price for the company. Cantor Fitzgerald initiated coverage on Anteris Technologies Global in a research report on Tuesday. They set an “overweight” rating and a $9.00 target price for the company. Finally, Barclays initiated coverage on Anteris Technologies Global in a research report on Tuesday. They set an “overweight” rating and a $22.00 target price for the company.
Check Out Our Latest Stock Report on Anteris Technologies Global
Anteris Technologies Global Trading Down 2.1 %
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Featured Articles
- Five stocks we like better than Anteris Technologies Global
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- 3 Stocks to Consider Buying in October
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Basic Materials Stocks Investing
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.